These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 25481688)

  • 1. Anti-thyroid antibodies in temporal lobe epilepsy-to check or not to check?
    Sethi NK
    Clin Neurol Neurosurg; 2015 Jan; 128():131. PubMed ID: 25481688
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithyroid antibodies as a potential marker of autoimmune-mediated late onset temporal lobe epilepsy.
    Miró J; Fortuny R; Juncadella M; Aiguabella M; Veciana M; Castañer S; Santurino M; Falip M
    Clin Neurol Neurosurg; 2014 Jun; 121():46-50. PubMed ID: 24793474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epilepsy associated with glutamic acid decarboxylase antibody (GADA).
    Liimatainen S; Peltola J
    Eur J Neurol; 2012 Jun; 19(6):799. PubMed ID: 22248348
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies.
    Falip M; Carreño M; Miró J; Saiz A; Villanueva V; Quílez A; Molins A; Barceló I; Sierra A; Graus F
    Eur J Neurol; 2012 Jun; 19(6):827-33. PubMed ID: 22353320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal lobe epilepsy and anti glutamic acid decarboxylase autoimmunity.
    Errichiello L; Striano S; Zara F; Striano P
    Neurol Sci; 2011 Aug; 32(4):547-50. PubMed ID: 21468678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of glutamic acid decarboxylase antibodies in childhood epilepsies.
    Rantala H; Kulmala P; Savola K; Knip M
    Pediatr Neurol; 1999 Nov; 21(5):794-6. PubMed ID: 10593668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal-lobe epilepsy associated with glutamic-acid-decarboxylase autoantibodies.
    Giometto B; Nicolao P; Macucci M; Tavolato B; Foxon R; Bottazzo GF
    Lancet; 1998 Aug; 352(9126):457. PubMed ID: 9708763
    [No Abstract]   [Full Text] [Related]  

  • 8. Long latency between GAD-antibody detection and development of limbic encephalitis--a case report.
    Fauser S; Uttner I; Ariño H; Scherbaum WA; Saiz A; Lewerenz J
    BMC Neurol; 2015 Sep; 15():177. PubMed ID: 26420440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies.
    Malter MP; Frisch C; Zeitler H; Surges R; Urbach H; Helmstaedter C; Elger CE; Bien CG
    Seizure; 2015 Aug; 30():57-63. PubMed ID: 26216686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Musicogenic reflex seizures in epilepsy with glutamic acid decarbocylase antibodies.
    Falip M; Rodriguez-Bel L; Castañer S; Miro J; Jaraba S; Mora J; Bas J; Carreño M
    Acta Neurol Scand; 2018 Feb; 137(2):272-276. PubMed ID: 28766694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Autoimmune epilepsy' or exasperated search for the etiology of seizures of unknown origin?
    Striano P; Minetti C
    Epilepsy Behav; 2012 Nov; 25(3):440-1. PubMed ID: 23036614
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical characteristics of four patients with temporal lobe epilepsy associated with elevated anti-GAD antibodies].
    Akaishi T; Jin K; Kato K; Itabashi H; Misu T; Tateyama M; Iwasaki M; Aoki M; Nakasato N
    Rinsho Shinkeigaku; 2015; 55(11):804-9. PubMed ID: 26369378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy.
    Liimatainen S; Peltola M; Sabater L; Fallah M; Kharazmi E; Haapala AM; Dastidar P; Knip M; Saiz A; Peltola J
    Epilepsia; 2010 May; 51(5):760-7. PubMed ID: 19817821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical features of temporal lobe epilepsy and the functional state of the thyroid].
    Shutov AA; Prostakova TI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(6):49-53. PubMed ID: 6180575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of anti-glutamic acid decarboxylase antibodies with different neurological findings in childhood.
    Ozkan M; Aksoy A; Çenesiz F; Atay NE; Yüksel D
    Epilepsy Behav; 2012 Nov; 25(3):464-7. PubMed ID: 22995927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathology in drug resistant mesial temporal lobe epilepsy with different types of hippocampal sclerosis.
    Tezer FI; Firat A; Tuzun E; Unal I; Soylemezoglu F; Bilginer B; Kaymaz F; Oguz KK; Saygi S
    Int J Neurosci; 2018 May; 128(5):421-428. PubMed ID: 28988523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to steroid treatment in anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia, stiff person syndrome and polyendocrinopathy.
    Kim JY; Chung EJ; Kim JH; Jung KY; Lee WY
    Mov Disord; 2006 Dec; 21(12):2263-4. PubMed ID: 17013903
    [No Abstract]   [Full Text] [Related]  

  • 18. GADA positivity at onset of type 1 diabetes is a risk factor for the development of autoimmune thyroiditis.
    Kordonouri O; Charpentier N; Hartmann R
    Pediatr Diabetes; 2011 Feb; 12(1):31-3. PubMed ID: 20723098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of thyroid and islet autoantibodies in type 1 diabetes mellitus.
    Prázný M; Skrha J; Límanová Z; Hilgertová J
    Sb Lek; 1999; 100(3):205-11. PubMed ID: 11221467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis.
    Malter MP; Helmstaedter C; Urbach H; Vincent A; Bien CG
    Ann Neurol; 2010 Apr; 67(4):470-8. PubMed ID: 20437582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.